Recent Press

Life Science CRE Looks To East Bay

Since Genentech planted its flag in South San Francisco in 1976, the city has remained the epicenter of the Bay Area life science industry.

The biotech behemoth is now the largest of over 200 biotech companies in South San Francisco, which contains over 11.5M SF and counting of biotech space, according to the city website.

BioMed Realty is well into construction of its 1.4M SF Gateway of Pacific development, with the 479K SF first phase already leased to AbbVie. Phase 3 Real Estate Partners’ recently opened the 21-floor north tower of its 715K SF Genesis project. Kilroy Realty Corp. is beginning construction on 630K SF across three buildings at Oyster Point, the San Francisco Business Times reports.


Woodstock Development President Kirk Syme To Discuss The Union 1.2 @ BART

WHAT YOU'LL LEARN

1. Who are the major development players currently building life sciences campuses, facilities, and buildings on the Peninsula?

2. What is the relationship like between the life sciences and biotech companies (from startup to IPO) and CRE developers and investors?

3. Is there adequate demand in place for the vast amount of supply under development or proposed?

4. What are the benefits (and challenges) of developing CRE for the life sciences industry?

5. What other neighborhoods across the Bay Area can support and sustain life sciences development of this magnitude?

Contact Information

330 Primrose Road, Suite 203
Burlingame, California 94010

Phone: 650.579.1901

Email:
Lisa Stephenson
lstephenson@woodstockdevelopment.com
Emmy Allgood
eallgood@woodstockdevelopment.com